Prepared by EmpowerMed
Goodward Health, Sample Client Dashboard
Multi-specialty physician group · 5 providers · Primary care, pediatrics and wound care
Revenue Overview
Year to date, January – October 2026, by payment date · Updated Nov 16, 2026
Payments by month, last 12 months
Nov 2025 – Oct 2026. January through October 2026 are highlighted (year to date).
Charges vs payments by payer group
$2,003k
$1,002k
$781k
$718k
$365k
$253k
$169k
$141k
$80k
Paid by rendering provider
Includes insurance and patient payments. Total $5,794,080.
Top payers by paid, Year to date
| Payer | Claims paid | Paid | % of period | Avg per claim | Pay lag | $0 rate |
|---|---|---|---|---|---|---|
| Medicare | 9,321 | $2,003,146 | 36.3% | $214.91 | 17.2 d | 5.5% |
| BCBS | 5,443 | $1,001,742 | 18.2% | $184.04 | 23.6 d | 9.1% |
| Aetna | 4,322 | $780,862 | 14.2% | $180.67 | 25.7 d | 10.5% |
| UHC | 4,553 | $718,031 | 13.0% | $157.71 | 29 d | 12.8% |
| Cigna | 2,205 | $365,146 | 6.6% | $165.60 | 27.9 d | 11.0% |
| Humana | 1,743 | $252,592 | 4.6% | $144.92 | 33.3 d | 15.2% |
| Medicaid | 2,544 | $168,620 | 3.1% | $66.28 | 36.5 d | 17.0% |
| TRICARE | 925 | $140,545 | 2.6% | $151.94 | 40.8 d | 8.1% |
| Other | 818 | $80,166 | 1.5% | $98.00 | 44 d | 19.0% |
| All insurance | 31,874 | $5,510,850 | 100% | $172.89 | 25.7 d | 10.1% |
Top 10 codes by paid (CPT / HCPCS)
| Code | Description | Units | Paid |
|---|---|---|---|
| 99214 | Office visit, established, moderate | 10,059 | $884,794 |
| 99213 | Office visit, established, low | 11,382 | $662,748 |
| A2032 | Skin substitute product | 66 | $545,644 |
| A2024 | Skin substitute product | 44 | $356,559 |
| 99396 | Preventive visit, 40-64 | 2,273 | $330,017 |
| Q4322 | Skin substitute product | 30 | $308,038 |
| 99204 | Office visit, new, moderate | 1,815 | $266,829 |
| Q4186 | Skin substitute product | 36 | $176,799 |
| 99215 | Office visit, established, high | 1,255 | $154,703 |
| G2211 | Visit complexity add-on | 7,959 | $127,316 |
Top 5 things going well
- Year-to-date payments are $5,794,080 across January through October, with October the strongest month.
- Medicare has paid $2,003,146 year to date, about 36% of insurance collections, and remains the fastest major payer.
- The graft program has paid $1.41 million so far this year, a steady climb from January through October.
- Vaccine volume is 3,446 doses year to date, with the October flu push the largest month.
- Average pay lag for the year is 25.7 days, and it has been improving toward the 23.9-day October figure.
Top opportunities & action plan
- The year-to-date $0-paid line rate is 10.1%. It has come down each month since spring, and the November claim-scrubber update is meant to keep that trend going.
- Humana and Medicaid remain the slowest payers for the year. Electronic remittance for Humana and weekly Medicaid follow-up should pull those lags closer to the group average.
- Collections ÷ charges is 41% for the year. Your fee schedule sits well above contracted rates. A fee schedule review would make charges and AR reflect real expected value.
- NP Reyes was still joining several plans for much of the year. Open enrollments are on the Credentialing tab; each approval should lift new-patient volume.
- Patient payments are about 5% of year-to-date cash. Text-to-pay statements typically lift patient collections 10 to 15%.
October 2026, by payment date · Updated Nov 16, 2026
Payments by month, last 12 months
Nov 2025 – Oct 2026. October is the highlighted bar.
Charges vs payments by payer group
$237k
$118k
$92k
$85k
$43k
$30k
$20k
$17k
$9k
Paid by rendering provider
Includes insurance and patient payments. Total $683,140.
Top payers by paid, October 2026
| Payer | Claims paid | Paid | % of period | Avg per claim | Pay lag | $0 rate |
|---|---|---|---|---|---|---|
| Medicare | 1,048 | $236,880 | 36.3% | $226.03 | 16 d | 4.1% |
| BCBS | 612 | $118,460 | 18.2% | $193.56 | 22 d | 6.8% |
| Aetna | 486 | $92,340 | 14.2% | $190.00 | 24 d | 7.9% |
| UHC | 512 | $84,910 | 13.0% | $165.84 | 27 d | 9.6% |
| Cigna | 248 | $43,180 | 6.6% | $174.11 | 26 d | 8.2% |
| Humana | 196 | $29,870 | 4.6% | $152.40 | 31 d | 11.4% |
| Medicaid | 286 | $19,940 | 3.1% | $69.72 | 34 d | 12.7% |
| TRICARE | 104 | $16,620 | 2.6% | $159.81 | 38 d | 6.1% |
| Other | 92 | $9,480 | 1.5% | $103.04 | 41 d | 14.3% |
| All insurance | 3,584 | $651,680 | 100% | $181.83 | 23.9 d | 7.4% |
Top 10 codes by paid (CPT / HCPCS)
| Code | Description | Units | Paid |
|---|---|---|---|
| 99214 | Office visit, established, moderate | 1,186 | $104,320 |
| 99213 | Office visit, established, low | 1,342 | $78,140 |
| A2032 | Skin substitute product | 9 | $71,280 |
| A2024 | Skin substitute product | 6 | $46,740 |
| Q4322 | Skin substitute product | 4 | $39,520 |
| 99396 | Preventive visit, 40-64 | 268 | $38,910 |
| 99204 | Office visit, new, moderate | 214 | $31,460 |
| Q4186 | Skin substitute product | 5 | $22,960 |
| 99215 | Office visit, established, high | 148 | $18,240 |
| G2211 | Visit complexity add-on | 1,104 | $17,660 |
Top 5 things going well
- Total payments reached $683,140, the strongest month of the last 12 and up 10.4% over September.
- Medicare is paying in 16 days on average with a 4.1% $0 rate, our cleanest payer.
- AR over 90 days is 14.8% as of Nov 16, 2026, after our team worked the oldest UHC and Humana balances.
- The visit-complexity add-on (G2211) is now captured on 1,104 eligible visits, up from under 600 in July.
- The graft program and the flu season vaccine push together added over $200k in paid this month.
Top opportunities & action plan
- UHC $0 rate is 9.6%. Most are modifier 25 edits on same-day procedures. We updated the claim scrubber rule on Nov 3 and are re-billing 41 lines this week.
- Humana pays slowest at 31 days. We are moving Humana to electronic remittance so payments post 5 to 7 days sooner.
- Collections ÷ charges is 43%. Your fee schedule is set far above top payer rates. We recommend a fee schedule review so charges and AR reflect real expected value.
- New-patient visits (99204) dipped 6%. Two payer panels for NP Reyes are still in process; see the Credentialing tab.
- Patient balances are 5% of cash. Turning on text-to-pay statements typically lifts patient collections 10 to 15%.
September 2026, by payment date · Updated Nov 16, 2026
Payments by month, last 12 months
Nov 2025 – Oct 2026. September is the highlighted bar.
Charges vs payments by payer group
$214k
$107k
$83k
$77k
$39k
$27k
$18k
$15k
$9k
Paid by rendering provider
Includes insurance and patient payments. Total $618,940.
Top payers by paid, September 2026
| Payer | Claims paid | Paid | % of period | Avg per claim | Pay lag | $0 rate |
|---|---|---|---|---|---|---|
| Medicare | 995 | $213,846 | 36.3% | $214.92 | 16.6 d | 4.7% |
| BCBS | 581 | $106,941 | 18.2% | $184.06 | 22.8 d | 7.7% |
| Aetna | 461 | $83,361 | 14.2% | $180.83 | 24.9 d | 9.0% |
| UHC | 486 | $76,653 | 13.0% | $157.72 | 28 d | 10.9% |
| Cigna | 235 | $38,981 | 6.6% | $165.88 | 27 d | 9.3% |
| Humana | 186 | $26,965 | 4.6% | $144.97 | 32.2 d | 13.0% |
| Medicaid | 272 | $18,001 | 3.1% | $66.18 | 35.3 d | 14.5% |
| TRICARE | 99 | $15,004 | 2.6% | $151.56 | 39.4 d | 6.9% |
| Other | 87 | $8,558 | 1.5% | $98.37 | 42.5 d | 16.3% |
| All insurance | 3,402 | $588,310 | 100% | $172.93 | 24.8 d | 8.6% |
Top 10 codes by paid (CPT / HCPCS)
| Code | Description | Units | Paid |
|---|---|---|---|
| 99214 | Office visit, established, moderate | 1,075 | $94,516 |
| 99213 | Office visit, established, low | 1,216 | $70,797 |
| A2032 | Skin substitute product | 8 | $61,280 |
| Q4322 | Skin substitute product | 4 | $39,490 |
| A2024 | Skin substitute product | 5 | $38,950 |
| 99396 | Preventive visit, 40-64 | 243 | $35,253 |
| 99204 | Office visit, new, moderate | 194 | $28,503 |
| Q4186 | Skin substitute product | 4 | $20,780 |
| 99215 | Office visit, established, high | 134 | $16,526 |
| G2211 | Visit complexity add-on | 1,000 | $16,000 |
Top 5 things going well
- Total payments were $618,940 in September, up 2.3% over August and the second-strongest month of the last 12.
- Medicare paid in 16.6 days on average, still the cleanest major payer.
- Collections ÷ charges improved to 41.3% from 40.8% in August.
- The graft program paid $163,700, already close to the later October high.
- Average pay lag improved to 24.8 days from 25.6 days in August.
Top opportunities & action plan
- The $0-paid line rate was 8.6%. Eligibility and modifier 25 edits were the main drivers. The scrubber update in early November is aimed at this.
- Humana and Medicaid were the slowest payers. Electronic remittance for Humana and a weekly follow-up list for Medicaid were already in motion by month-end.
- Collections ÷ charges is still 41%. A fee schedule review would bring charges closer to contracted rates so AR reflects real expected value.
- NP Reyes was still out of network with several plans in September. See the Credentialing tab for the enrollments that opened in October and November.
- Patient collections were about 5% of cash. Text-to-pay statements would typically lift patient collections 10 to 15%.
AR & Denials
AR snapshot as of Nov 16, 2026. Aging, payer balances and open claims do not change with the period menu. Denial counts and the $0-paid rate follow the menu.
AR aging
| Bucket | Balance | Claims | % of AR |
|---|---|---|---|
| 0–30 days | $825,000 | 1,846 | 58.4% |
| 31–60 days | $243,000 | 612 | 17.2% |
| 61–90 days | $135,600 | 318 | 9.6% |
| 91–120 days | $89,000 | 187 | 6.3% |
| 120+ days | $120,000 | 241 | 8.5% |
| Total | $1,412,600 | 3,204 | 100% |
Snapshot as of Nov 16, 2026. These balances do not change with the period menu.
AR by payer
| Payer | Balance | % over 90 |
|---|---|---|
| Medicare | $412,800 | 6.6% |
| BCBS | $268,400 | 12.9% |
| UHC | $221,700 | 21.4% |
| Aetna | $186,300 | 14.1% |
| Cigna | $88,900 | 13.6% |
| Humana | $76,200 | 24.8% |
| Medicaid | $58,400 | 27.3% |
| TRICARE | $41,700 | 18.2% |
| Other / self-pay | $58,200 | 31.5% |
| Total | $1,412,600 | 14.8% |
Snapshot as of Nov 16, 2026.
Denials by reason, Year to date
5,062 denied lines, January through October 2026. Other $0 lines went to patient deductible or were paid in a bundled line.
Denials by reason, October 2026
412 denied lines in October 2026. Other $0 lines went to patient deductible or were paid in a bundled line.
Denials by reason, September 2026
450 denied lines in September 2026. Other $0 lines went to patient deductible or were paid in a bundled line.
AR & denial trend, last 6 months
| Month | Days in AR | AR over 90 | $0 rate | Denied lines |
|---|---|---|---|---|
| May | 38.2 | 21.4% | 10.9% | 521 |
| Jun | 36.9 | 20.1% | 10.2% | 498 |
| Jul | 36.1 | 19.3% | 9.7% | 486 |
| Aug | 35.4 | 18.2% | 9.1% | 471 |
| Sep | 33.9 | 16.9% | 8.6% | 450 |
| Oct | 31.6 | 14.8% | 7.4% | 412 |
Days in AR and AR over 90 days are snapshots (latest as of Nov 16). $0 rate and denied lines are monthly. Every measure has improved five months in a row.
Outstanding claims, payer issues
| Payer | Issue | Claims | Unpaid | Avg | Status |
|---|---|---|---|---|---|
| UHC | Modifier 25 edit on same-day procedure | 41 | $7,380 | $180 | Corrected, re-billed |
| Humana | Payer ID change, claims rejected at clearinghouse | 27 | $4,860 | $180 | Delayed by payer ID |
| Aetna | Graft records requested | 3 | $24,600 | $8,200 | Records sent 11/6 |
| BCBS | Prior auth on file not linked to claim | 12 | $3,240 | $270 | Reprocessing requested |
| Medicaid | Submitted, no response after 45 days | 18 | $2,160 | $120 | Submitted / unpaid |
| Cigna | Underpaid vs contract rate | 22 | $1,980 | $90 | Appeal filed 11/9 |
Open items as of Nov 16, 2026. This list does not change with the period menu.
How to read this tab
Days in AR: total AR ÷ average daily charges, as of the snapshot date. Under 35 days is healthy for a group like yours. It does not change with the period menu.
AR over 90 days: the share of your balance older than 90 days as of the snapshot date. This is the money most at risk.
$0-paid line rate: claim lines a payer paid at $0 in the selected period. It is our early warning for denials, before the remit codes come back.
Top 5 things going well
- Days in AR is 31.6 as of Nov 16, 2026, back under our 35-day goal.
- 0–30 day AR is 58% of the total, which means new claims are paying on schedule.
- Eligibility denials have been trending down since real-time eligibility checks started at check-in.
- 78% of appeals filed in the last 30 days were overturned.
- Medicare AR over 90 days is only 6%.
Top opportunities & action plan
- Eligibility is still the top denial reason. We will send the front desk a weekly list of patients with coverage changes before their visit.
- Humana claims are held up by a payer ID change. We updated the payer ID on Nov 12 and are resubmitting all 27 claims this week.
- Medicaid has 27% of its balance over 90 days. We escalated 18 unanswered claims to provider relations and will call weekly until they pay.
- Prior auth denials remain a steady share of denied lines. We are adding an auth-required check at scheduling for imaging, injections and grafts.
- Three Aetna graft claims total $24.6k. Wound photos and measurements went in Nov 6. We follow up every 7 days.
Wound Care & Grafts
Year to date, January – October 2026, graft program, by payment date · Updated Nov 16, 2026
Product & application breakdown by code
| Code | Description | Category | Lines | Paid | Avg paid | Paid lines | $0 lines | Denial % |
|---|---|---|---|---|---|---|---|---|
| A2032 | Skin substitute, per sq cm | Product | 66 | $545,644 | $8,801 | 62 | 4 | 6% |
| A2024 | Skin substitute, per sq cm | Product | 44 | $356,559 | $8,490 | 42 | 2 | 5% |
| Q4186 | Skin substitute, per sq cm | Product | 36 | $176,799 | $5,358 | 33 | 3 | 8% |
| Q4322 | Skin substitute, per sq cm | Product | 30 | $308,038 | $11,001 | 28 | 2 | 7% |
| 15271 | Application, trunk/arms/legs, first 25 sq cm | Application | 109 | $11,690 | $126 | 93 | 16 | 15% |
| 15272 | Application, each additional 25 sq cm | Application | 70 | $2,918 | $62 | 47 | 23 | 33% |
| 15273 | Application, trunk/arms/legs, first 100 sq cm | Application | 62 | $9,305 | $172 | 54 | 8 | 13% |
| 15274 | Application, each additional 100 sq cm | Application | 40 | $2,278 | $95 | 24 | 16 | 40% |
| Total | 457 | $1,413,231 | 383 | 74 | 16% |
Grafts by provider
| Provider | Grafts | Product paid | Application paid | Total |
|---|---|---|---|---|
| Dr. Elena Marsh | 110 | $871,516 | $16,820 | $888,336 |
| Dr. Victor Hale | 44 | $344,634 | $6,144 | $350,778 |
| NP Jordan Reyes | 22 | $170,890 | $3,227 | $174,117 |
| Total | 176 | $1,387,040 | $26,191 | $1,413,231 |
Graft payments by month
Graft product paid, payer × product
| Payer | A2032 | A2024 | Q4186 | Q4322 | Total |
|---|---|---|---|---|---|
| Medicare | $368,662 | $172,440 | $105,039 | $231,011 | $877,152 |
| BCBS | $109,500 | $63,893 | — | $77,027 | $250,420 |
| Aetna | $67,482 | $60,285 | $71,760 | — | $199,527 |
| UHC | — | $59,941 | — | — | $59,941 |
| Total | $545,644 | $356,559 | $176,799 | $308,038 | $1,387,040 |
Graft program, last 6 months
| Month | Grafts | Product paid | Application paid | Total paid | Avg paid per graft | Product $0 rate |
|---|---|---|---|---|---|---|
| May | 17 | $135,720 | $2,480 | $138,200 | $8,482 | 6% |
| Jun | 18 | $143,690 | $2,610 | $146,300 | $8,452 | 6% |
| Jul | 19 | $150,140 | $2,760 | $152,900 | $8,341 | 5% |
| Aug | 19 | $147,110 | $2,690 | $149,800 | $8,173 | 5% |
| Sep | 21 | $160,500 | $3,200 | $163,700 | $8,025 | 5% |
| Oct | 24 | $180,500 | $3,331 | $183,831 | $8,205 | 8% |
| 6 months | 118 | $917,660 | $17,071 | $934,731 | $8,267 | 6% |
Grafts are up 41% since May while avg paid per graft held between $8,000 and $8,500. Year-to-date figures above include January through April as well.
How to read this tab
Product vs application: product is the skin substitute itself, billed per sq cm. Application is the procedure code for placing it.
Avg paid per graft: product paid ÷ product lines paid above $0, so one denied line does not drag the average down.
Denial %: lines paid at $0 ÷ all lines for that code in the selected period. Add-on codes deny most often, so we watch them closely.
Top 5 things going well
- The graft program has paid $1,413,231 year to date, with volume rising from 14 grafts in January to 24 in October.
- Average paid per graft is $8,406 on 165 paid product lines.
- Product dollars are 98% of the program; application codes are a small, steady share.
- Dr. Marsh has applied 110 of the 176 grafts this year.
- Medicare remains the largest graft payer across every product.
Top opportunities & action plan
- Add-on application codes have the highest $0 rates for the year. Unit-to-wound-size checks before billing are meant to bring those denials down.
- A few product lines still deny for diagnosis or prior auth. Covered-diagnosis and UHC auth checks are now in the visit workflow.
- Aetna records requests have held up a handful of large claims. We now send photos and measurements with the first submission when we can.
- Humana has no graft product payments in the payer grid. That is a coverage mix, not a $0: Humana volume in this program is very small.
- Product cost is not tracked yet. Share invoice cost per product and we will add margin per graft to this tab.
October 2026, graft program, by payment date · Updated Nov 16, 2026
Product & application breakdown by code
| Code | Description | Category | Lines | Paid | Avg paid | Paid lines | $0 lines | Denial % |
|---|---|---|---|---|---|---|---|---|
| A2032 | Skin substitute, per sq cm | Product | 9 | $71,280 | $8,910 | 8 | 1 | 11% |
| A2024 | Skin substitute, per sq cm | Product | 6 | $46,740 | $7,790 | 6 | 0 | 0% |
| Q4186 | Skin substitute, per sq cm | Product | 5 | $22,960 | $5,740 | 4 | 1 | 20% |
| Q4322 | Skin substitute, per sq cm | Product | 4 | $39,520 | $9,880 | 4 | 0 | 0% |
| 15271 | Application, trunk/arms/legs, first 25 sq cm | Application | 14 | $1,488 | $124 | 12 | 2 | 14% |
| 15272 | Application, each additional 25 sq cm | Application | 9 | $372 | $62 | 6 | 3 | 33% |
| 15273 | Application, trunk/arms/legs, first 100 sq cm | Application | 8 | $1,183 | $169 | 7 | 1 | 12% |
| 15274 | Application, each additional 100 sq cm | Application | 5 | $288 | $96 | 3 | 2 | 40% |
| Total | 60 | $183,831 | 50 | 10 | 17% |
Grafts by provider
| Provider | Grafts | Product paid | Application paid | Total |
|---|---|---|---|---|
| Dr. Elena Marsh | 15 | $113,420 | $2,140 | $115,560 |
| Dr. Victor Hale | 6 | $44,860 | $780 | $45,640 |
| NP Jordan Reyes | 3 | $22,220 | $411 | $22,631 |
| Total | 24 | $180,500 | $3,331 | $183,831 |
Graft payments by month
Graft product paid, payer × product
| Payer | A2032 | A2024 | Q4186 | Q4322 | Total |
|---|---|---|---|---|---|
| Medicare | $48,190 | $22,610 | $13,780 | $29,640 | $114,220 |
| BCBS | $14,260 | $8,240 | — | $9,880 | $32,380 |
| Aetna | $8,830 | $7,790 | $9,180 | — | $25,800 |
| UHC | — | $8,100 | — | — | $8,100 |
| Total | $71,280 | $46,740 | $22,960 | $39,520 | $180,500 |
Graft program, last 6 months
| Month | Grafts | Product paid | Application paid | Total paid | Avg paid per graft | Product $0 rate |
|---|---|---|---|---|---|---|
| May | 17 | $135,720 | $2,480 | $138,200 | $8,482 | 6% |
| Jun | 18 | $143,690 | $2,610 | $146,300 | $8,452 | 6% |
| Jul | 19 | $150,140 | $2,760 | $152,900 | $8,341 | 5% |
| Aug | 19 | $147,110 | $2,690 | $149,800 | $8,173 | 5% |
| Sep | 21 | $160,500 | $3,200 | $163,700 | $8,025 | 5% |
| Oct | 24 | $180,500 | $3,331 | $183,831 | $8,205 | 8% |
| 6 months | 118 | $917,660 | $17,071 | $934,731 | $8,267 | 6% |
Grafts are up 41% since May while avg paid per graft held between $8,000 and $8,500. Year-to-date figures above include January through April as well.
How to read this tab
Product vs application: product is the skin substitute itself, billed per sq cm. Application is the procedure code for placing it.
Avg paid per graft: product paid ÷ product lines paid above $0, so one denied line does not drag the average down.
Denial %: lines paid at $0 ÷ all lines for that code in the selected period. Add-on codes deny most often, so we watch them closely.
Top 5 things going well
- Graft program paid $183,831 in October, the best month this year.
- Average paid per graft is $8,205, holding steady as volume grew.
- Medicare graft claims paid with no product denials this month.
- Every graft claim now goes out with wound size, location and product lot number attached.
- Q4322 paid 4 of 4 lines at an average near $9,900.
Top opportunities & action plan
- Add-on application codes deny most often. 15272 and 15274 denied 5 of 14 lines. We are checking units against the documented wound size before billing.
- Q4186 had one $0 line. The plan wanted a different covered diagnosis. We corrected the code and appealed on Nov 10.
- Three Aetna claims are waiting on records. Records went Nov 6. Expect payment within 30 days of review.
- UHC requires prior auth for A2024. We now request auth at the wound care visit before the product is ordered.
- Product cost is not tracked yet. Share invoice cost per product and we will add margin per graft to this tab.
September 2026, graft program, by payment date · Updated Nov 16, 2026
Product & application breakdown by code
| Code | Description | Category | Lines | Paid | Avg paid | Paid lines | $0 lines | Denial % |
|---|---|---|---|---|---|---|---|---|
| A2032 | Skin substitute, per sq cm | Product | 8 | $61,280 | $8,754 | 7 | 1 | 12% |
| A2024 | Skin substitute, per sq cm | Product | 5 | $38,950 | $7,790 | 5 | 0 | 0% |
| Q4186 | Skin substitute, per sq cm | Product | 4 | $20,780 | $5,195 | 4 | 0 | 0% |
| Q4322 | Skin substitute, per sq cm | Product | 4 | $39,490 | $9,872 | 4 | 0 | 0% |
| 15271 | Application, trunk/arms/legs, first 25 sq cm | Application | 13 | $1,420 | $129 | 11 | 2 | 15% |
| 15272 | Application, each additional 25 sq cm | Application | 8 | $350 | $70 | 5 | 3 | 38% |
| 15273 | Application, trunk/arms/legs, first 100 sq cm | Application | 7 | $1,140 | $190 | 6 | 1 | 14% |
| 15274 | Application, each additional 100 sq cm | Application | 5 | $290 | $97 | 3 | 2 | 40% |
| Total | 54 | $163,700 | 45 | 9 | 17% |
Grafts by provider
| Provider | Grafts | Product paid | Application paid | Total |
|---|---|---|---|---|
| Dr. Elena Marsh | 13 | $100,800 | $2,050 | $102,850 |
| Dr. Victor Hale | 5 | $39,800 | $760 | $40,560 |
| NP Jordan Reyes | 3 | $19,900 | $390 | $20,290 |
| Total | 21 | $160,500 | $3,200 | $163,700 |
Graft payments by month
Graft product paid, payer × product
| Payer | A2032 | A2024 | Q4186 | Q4322 | Total |
|---|---|---|---|---|---|
| Medicare | $41,200 | $18,800 | $11,400 | $29,600 | $101,000 |
| BCBS | $12,600 | $7,900 | — | $9,890 | $30,390 |
| Aetna | $7,480 | $7,350 | $9,380 | — | $24,210 |
| UHC | — | $4,900 | — | — | $4,900 |
| Total | $61,280 | $38,950 | $20,780 | $39,490 | $160,500 |
Graft program, last 6 months
| Month | Grafts | Product paid | Application paid | Total paid | Avg paid per graft | Product $0 rate |
|---|---|---|---|---|---|---|
| May | 17 | $135,720 | $2,480 | $138,200 | $8,482 | 6% |
| Jun | 18 | $143,690 | $2,610 | $146,300 | $8,452 | 6% |
| Jul | 19 | $150,140 | $2,760 | $152,900 | $8,341 | 5% |
| Aug | 19 | $147,110 | $2,690 | $149,800 | $8,173 | 5% |
| Sep | 21 | $160,500 | $3,200 | $163,700 | $8,025 | 5% |
| Oct | 24 | $180,500 | $3,331 | $183,831 | $8,205 | 8% |
| 6 months | 118 | $917,660 | $17,071 | $934,731 | $8,267 | 6% |
Grafts are up 41% since May while avg paid per graft held between $8,000 and $8,500. Year-to-date figures above include January through April as well.
How to read this tab
Product vs application: product is the skin substitute itself, billed per sq cm. Application is the procedure code for placing it.
Avg paid per graft: product paid ÷ product lines paid above $0, so one denied line does not drag the average down.
Denial %: lines paid at $0 ÷ all lines for that code in the selected period. Add-on codes deny most often, so we watch them closely.
Top 5 things going well
- Graft program paid $163,700 in September, up from August and already close to the later October high.
- Average paid per graft is $8,025, in the same $8,000 to $8,500 range as the rest of the year.
- 21 grafts were applied, 3 more than August.
- Q4322 paid all 4 lines.
- Dr. Marsh continues to drive most of the graft volume.
Top opportunities & action plan
- Add-on application codes denied most often. We started checking units against documented wound size before billing, ahead of the October claims.
- A2032 had one $0 line. The diagnosis on the claim did not match the plan's covered list. It was corrected the following week.
- Aetna records requests were already open by month-end. Photos and measurements went in Nov 6.
- UHC prior auth for A2024 was still being built into the visit workflow. Auth is now requested at the wound care visit before the product is ordered.
- Product cost is not tracked yet. Share invoice cost per product and we will add margin per graft to this tab.
Vaccines
Year to date, January – October 2026, vaccine program, by payment date · Updated Nov 16, 2026
Vaccine product by code
| CPT | Vaccine | Doses | VFC | Private | Paid | Paid per private dose |
|---|---|---|---|---|---|---|
| 90686 | Influenza, quadrivalent | 506 | 204 | 302 | $6,252 | $20.70 |
| 90670 | Pneumococcal conjugate (PCV) | 554 | 247 | 307 | $69,320 | $225.80 |
| 90651 | HPV, 9-valent | 460 | 177 | 283 | $75,934 | $268.32 |
| 90716 | Varicella | 434 | 203 | 231 | $32,838 | $142.16 |
| 90707 | MMR | 462 | 216 | 246 | $20,281 | $82.44 |
| 90700 | DTaP | 538 | 246 | 292 | $8,114 | $27.79 |
| 90648 | Hib | 492 | 229 | 263 | $5,371 | $20.42 |
| Total | 3,446 | 1,522 | 1,924 | $218,110 | $113.36 |
VFC (Vaccines for Children) doses are state-supplied, so only the administration is paid.
Administration codes
| CPT | Description | Units | Paid | Paid per unit |
|---|---|---|---|---|
| 90460 | Admin with counseling, first component | 1,761 | $40,679 | $23.10 |
| 90461 | Admin with counseling, each additional component | 1,404 | $20,779 | $14.80 |
| 90471 | Admin, first injection | 1,275 | $31,365 | $24.60 |
| 90472 | Admin, each additional injection | 831 | $12,632 | $15.20 |
| Total | 5,271 | $105,455 |
VFC vs private stock
| Stock | Doses | Paid | Paid per dose |
|---|---|---|---|
| VFC | 1,522 | $32,875 | $21.60 |
| Private stock | 1,924 | $290,690 | $151.09 |
VFC is paid for administration only. Private stock is paid for product plus administration.
Doses by month
Paid by vaccine, private stock
Vaccine program, last 6 months
| Month | Doses | VFC | Private | Paid | Paid per dose | $0 rate |
|---|---|---|---|---|---|---|
| May | 248 | 112 | 136 | $24,180 | $97.50 | 4.6% |
| Jun | 302 | 131 | 171 | $29,410 | $97.38 | 4.4% |
| Jul | 389 | 176 | 213 | $36,920 | $94.91 | 4.3% |
| Aug | 446 | 198 | 248 | $41,240 | $92.47 | 4.1% |
| Sep | 401 | 172 | 229 | $36,701 | $91.52 | 4.0% |
| Oct | 526 | 225 | 301 | $45,514 | $86.53 | 3.2% |
| 6 months | 2,312 | 1,014 | 1,298 | $213,965 | $92.55 |
Late-summer checkups (Jul–Aug) and flu season (Oct) drive the peaks. HPV and PCV are most of the product dollars. Year-to-date figures above also include January through April.
How to read this tab
VFC: Vaccines for Children stock is state-supplied for eligible patients, so only the administration is billed.
Paid per dose: all vaccine paid, product plus administration, ÷ doses given, VFC doses included, for the selected period.
Admin codes: 90460/90461 apply to counseling visits under age 19. 90471/90472 apply otherwise.
Top 5 things going well
- 3,446 doses have been given year to date, including the October flu peak.
- Vaccine collections are $323,565, with HPV and PCV the largest product lines.
- VFC accounts for 44% of doses; those visits are paid for administration only.
- Counseling codes 90460/90461 are billed on eligible visits under age 19.
- Paid per dose is a little lower in the fall because flu doses are a larger share of the mix.
Top opportunities & action plan
- Some 90461 units have been missed on combination vaccines. We are auditing those visits and re-billing short units.
- HPV series completion is low for the year. A recall text list would close the gap on dose 2.
- A few plans have paid PCV below contract. We are checking BCBS and Aetna vaccine payments against the contracted rate and will appeal shortfalls.
- VFC stock was used for a handful of privately insured patients. An eligibility check is now on the VFC log.
- No dose-level inventory view yet. Share the monthly lot log and we will add on-hand vs used to this tab.
October 2026, vaccine program, by payment date · Updated Nov 16, 2026
Vaccine product by code
| CPT | Vaccine | Doses | VFC | Private | Paid | Paid per private dose |
|---|---|---|---|---|---|---|
| 90686 | Influenza, quadrivalent | 186 | 74 | 112 | $2,397 | $21.40 |
| 90670 | Pneumococcal conjugate (PCV) | 72 | 33 | 39 | $9,411 | $241.31 |
| 90651 | HPV, 9-valent | 52 | 18 | 34 | $9,772 | $287.41 |
| 90716 | Varicella | 46 | 21 | 25 | $3,815 | $152.60 |
| 90707 | MMR | 48 | 22 | 26 | $2,301 | $88.50 |
| 90700 | DTaP | 64 | 30 | 34 | $1,013 | $29.79 |
| 90648 | Hib | 58 | 27 | 31 | $679 | $21.90 |
| Total | 526 | 225 | 301 | $29,388 | $97.63 |
VFC (Vaccines for Children) doses are state-supplied, so only the administration is paid.
Administration codes
| CPT | Description | Units | Paid | Paid per unit |
|---|---|---|---|---|
| 90460 | Admin with counseling, first component | 268 | $6,191 | $23.10 |
| 90461 | Admin with counseling, each additional component | 214 | $3,167 | $14.80 |
| 90471 | Admin, first injection | 196 | $4,822 | $24.60 |
| 90472 | Admin, each additional injection | 128 | $1,946 | $15.20 |
| Total | 806 | $16,126 |
VFC vs private stock
| Stock | Doses | Paid | Paid per dose |
|---|---|---|---|
| VFC | 225 | $4,860 | $21.60 |
| Private stock | 301 | $40,654 | $135.06 |
VFC is paid for administration only. Private stock is paid for product plus administration.
Doses by month
Paid by vaccine, private stock
Vaccine program, last 6 months
| Month | Doses | VFC | Private | Paid | Paid per dose | $0 rate |
|---|---|---|---|---|---|---|
| May | 248 | 112 | 136 | $24,180 | $97.50 | 4.6% |
| Jun | 302 | 131 | 171 | $29,410 | $97.38 | 4.4% |
| Jul | 389 | 176 | 213 | $36,920 | $94.91 | 4.3% |
| Aug | 446 | 198 | 248 | $41,240 | $92.47 | 4.1% |
| Sep | 401 | 172 | 229 | $36,701 | $91.52 | 4.0% |
| Oct | 526 | 225 | 301 | $45,514 | $86.53 | 3.2% |
| 6 months | 2,312 | 1,014 | 1,298 | $213,965 | $92.55 |
Late-summer checkups (Jul–Aug) and flu season (Oct) drive the peaks. HPV and PCV are most of the product dollars. Year-to-date figures above also include January through April.
How to read this tab
VFC: Vaccines for Children stock is state-supplied for eligible patients, so only the administration is billed.
Paid per dose: all vaccine paid, product plus administration, ÷ doses given, VFC doses included, for the selected period.
Admin codes: 90460/90461 apply to counseling visits under age 19. 90471/90472 apply otherwise.
Top 5 things going well
- 526 doses given in October, up 31% as flu season started.
- Administration codes paid on 97% of lines, including VFC doses.
- HPV and PCV paid more than $240 per private dose on average.
- Counseling codes 90460/90461 are billed on every eligible visit under age 19.
- Saturday flu clinics added 118 doses this month.
Top opportunities & action plan
- Some 90461 units are missing. Combination vaccines need one 90461 per extra component. We found 22 short units and re-billed them.
- HPV series completion is low. Only 41% of patients came back for dose 2. A recall text list would close this gap.
- Two plans paid PCV below contract. We are checking every BCBS and Aetna vaccine payment against the contracted rate and will appeal any shortfall.
- VFC stock was used for 3 privately insured patients. We flagged them for stock replacement and added an eligibility check to the VFC log.
- No dose-level inventory view yet. Share the monthly lot log and we will add on-hand vs used to this tab.
September 2026, vaccine program, by payment date · Updated Nov 16, 2026
Vaccine product by code
| CPT | Vaccine | Doses | VFC | Private | Paid | Paid per private dose |
|---|---|---|---|---|---|---|
| 90686 | Influenza, quadrivalent | 122 | 48 | 74 | $1,584 | $21.41 |
| 90670 | Pneumococcal conjugate (PCV) | 66 | 30 | 36 | $8,687 | $241.31 |
| 90651 | HPV, 9-valent | 44 | 16 | 28 | $8,047 | $287.39 |
| 90716 | Varicella | 38 | 18 | 20 | $3,052 | $152.60 |
| 90707 | MMR | 42 | 20 | 22 | $1,947 | $88.50 |
| 90700 | DTaP | 48 | 22 | 26 | $775 | $29.81 |
| 90648 | Hib | 41 | 18 | 23 | $504 | $21.91 |
| Total | 401 | 172 | 229 | $24,596 | $107.41 |
VFC (Vaccines for Children) doses are state-supplied, so only the administration is paid.
Administration codes
| CPT | Description | Units | Paid | Paid per unit |
|---|---|---|---|---|
| 90460 | Admin with counseling, first component | 210 | $4,851 | $23.10 |
| 90461 | Admin with counseling, each additional component | 165 | $2,442 | $14.80 |
| 90471 | Admin, first injection | 140 | $3,444 | $24.60 |
| 90472 | Admin, each additional injection | 90 | $1,368 | $15.20 |
| Total | 605 | $12,105 |
VFC vs private stock
| Stock | Doses | Paid | Paid per dose |
|---|---|---|---|
| VFC | 172 | $3,715 | $21.60 |
| Private stock | 229 | $32,986 | $144.04 |
VFC is paid for administration only. Private stock is paid for product plus administration.
Doses by month
Paid by vaccine, private stock
Vaccine program, last 6 months
| Month | Doses | VFC | Private | Paid | Paid per dose | $0 rate |
|---|---|---|---|---|---|---|
| May | 248 | 112 | 136 | $24,180 | $97.50 | 4.6% |
| Jun | 302 | 131 | 171 | $29,410 | $97.38 | 4.4% |
| Jul | 389 | 176 | 213 | $36,920 | $94.91 | 4.3% |
| Aug | 446 | 198 | 248 | $41,240 | $92.47 | 4.1% |
| Sep | 401 | 172 | 229 | $36,701 | $91.52 | 4.0% |
| Oct | 526 | 225 | 301 | $45,514 | $86.53 | 3.2% |
| 6 months | 2,312 | 1,014 | 1,298 | $213,965 | $92.55 |
Late-summer checkups (Jul–Aug) and flu season (Oct) drive the peaks. HPV and PCV are most of the product dollars. Year-to-date figures above also include January through April.
How to read this tab
VFC: Vaccines for Children stock is state-supplied for eligible patients, so only the administration is billed.
Paid per dose: all vaccine paid, product plus administration, ÷ doses given, VFC doses included, for the selected period.
Admin codes: 90460/90461 apply to counseling visits under age 19. 90471/90472 apply otherwise.
Top 5 things going well
- 401 doses were given in September, ahead of the October flu peak.
- HPV and PCV again made up most of the product dollars, at more than $240 per private dose.
- Administration codes paid on the great majority of lines, including VFC doses.
- Counseling codes 90460/90461 were billed on eligible visits under age 19.
- Paid per dose was $91.52, a little higher than October because the mix had fewer low-cost flu doses.
Top opportunities & action plan
- Some 90461 units were still being missed. We audited combination-vaccine visits and re-billed short units in November.
- HPV series completion was already a concern. A recall text list would bring more patients back for dose 2.
- A few PCV payments came in below contract. BCBS and Aetna vaccine payments are being checked against the contracted rate.
- VFC vs private stock still needed a tighter eligibility check. That check is now on the VFC log.
- No dose-level inventory view yet. Share the monthly lot log and we will add on-hand vs used to this tab.
Credentialing
Credentialing Report, week of Nov 16, 2026 · Source updated Nov 14, 2026 · Not tied to the billing-period menu
Credentialing report
Credentialing Report, week of Nov 16, 2026
Goodward Health · 5 providers · 8 plans · Source updated Nov 14, 2026
29 of 38 provider enrollments are approved. NP Reyes is the only provider still moving through plans, and two of those enrollments need something from you this week.
of 38 enrollments
(incl. on hold, not started)
from you
closed
(NA excluded)
29 of 38 enrollments approved. NA (plans a provider does not need) is excluded.
Action needed from you
- NP Reyes, BCBS: sign and return the updated participation agreement we emailed Nov 13.
- NP Reyes, Cigna: the plan needs a copy of the current DEA registration. Please upload it to the shared folder by Nov 20.
- Dr. Hale: re-attest the online credentialing profile by Dec 4 (we can walk you through it in 5 minutes).
What changed this week
- Aetna approved NP Reyes, effective 11/1/26.
- Humana put NP Reyes on hold until the BCBS agreement is signed.
- UHC confirmed Dr. Natarajan’s application is complete and in review.
- We opened a follow-up case with TRICARE on Dr. Natarajan (day 104).
Provider × plan status
| Provider | Medicare | Medicaid | Aetna | BCBS | UHC | Cigna | Humana | TRICARE |
|---|---|---|---|---|---|---|---|---|
| Dr. Elena MarshWound care | Approved3/1/24 | Approved5/1/24 | Approved4/15/24 | Approved6/1/24 | Approved5/15/24 | Approved7/1/24 | Approved8/1/24 | Approved9/1/24 |
| Dr. Victor HaleInternal medicine | Approved1/1/23 | Approved2/1/23 | Approved3/1/23 | Approved2/15/23 | Approved4/1/23 | Approved3/15/23 | Approved5/1/23 | Not acceptingPanel closed |
| Dr. Priya NatarajanPediatrics | Approved7/1/25 | Approved8/1/25 | Approved9/1/25 | Approved8/15/25 | In processSub 9/22/26 | Approved10/1/25 | NA | In processSub 8/4/26 |
| NP Jordan ReyesFamily medicine | Approved10/1/26 | In processSub 9/8/26 | Approved11/1/26 | Waiting on youSub 9/15/26 | In processSub 9/15/26 | Needs attentionSub 9/29/26 | On holdSub 10/2/26 | Not started |
| Dr. Samuel OrtegaFamily medicine | Approved6/1/22 | Approved6/1/22 | Approved7/1/22 | Approved7/1/22 | Approved8/1/22 | Approved8/1/22 | Approved9/1/22 | NA |
What the colors mean
Dates show the effective date when approved, or the submitted date while in process.
Expiring or due for renewal
| Item | Provider | Due | Days left | Who’s on it |
|---|---|---|---|---|
| Online credentialing profile re-attest | Dr. Victor Hale | Dec 4, 2026 | 18 | You (we prep it) |
| Malpractice policy | Dr. Samuel Ortega | Jan 15, 2027 | 60 | You, send renewal |
| State medical license | Dr. Priya Natarajan | Feb 28, 2027 | 104 | EmpowerMed reminder |
| DEA registration | NP Jordan Reyes | Mar 31, 2027 | 135 | EmpowerMed reminder |
| Medicare revalidation | Dr. Victor Hale | Jun 30, 2027 | 226 | EmpowerMed |
Avg days in process, by plan type
Open applications only, as of Nov 14.
Typical timelines
- Medicare30–60 days
- Commercial plans60–120 days
- TRICARE / VA90–180 days
- Re-credentialingAbout every 3 years
Effective date is the first date of service a plan will pay for. We track it so no visit is billed early.
Top 5 things going well
- 76% of enrollments are approved, up from 71% a month ago.
- Aetna approved NP Reyes in 47 days, well inside the normal range.
- Dr. Marsh is in network with all 8 plans, which protects the graft program.
- Every open application has a follow-up date, and none has gone 14 days without contact.
- No license or malpractice policy lapses in the next 60 days.
Top opportunities & action plan
- NP Reyes has 6 plans still open. Two need your signature or documents this week. Once returned, we expect BCBS and Cigna by mid-December.
- TRICARE for Dr. Natarajan is at day 104. Within the 90–180 day norm. We opened a case and will call every 10 days.
- Cigna flagged NP Reyes’ application. The DEA copy on file expired. Upload the current one and we resubmit the same day.
- Humana is on hold. It releases automatically once the BCBS agreement is signed. No extra action needed.
- Dr. Hale is closed at TRICARE. The panel is full in your area. We will reapply when it reopens and check monthly.
Want a dashboard like this for your practice?
EmpowerMed handles billing, coding and credentialing for physician groups, and every client gets a clear monthly dashboard built from their own data.
Sample dashboard for illustration only. Goodward Health, its providers and all figures are fictional and do not represent any EmpowerMed client.